Literature DB >> 19295393

Nimodipine prevents transient cognitive dysfunction after moderate hypoxia in adult mice.

Michael Haile1, Fred Limson, Kevin Gingrich, Yong-Sheng Li, David Quartermain, Thomas Blanck, Alex Bekker.   

Abstract

BACKGROUND: Cognitive changes associated with moderate hypoxia may be related to the elevation of cytosolic calcium (Ca) levels which may, in turn, affect neurotransmitter synthesis and metabolism. We tested whether treatment with nimodipine (NIMO), an L-type Ca channel blocker, would preserve working memory after hypoxic hypoxia.
METHODS: We randomized 157 Swiss-Webster, 30 to 35 g mice (6 to 8 wk) to 6 groups, which were exposed to the following gas mixtures for 1 hour: (1) O2 21%; (2) O2 21% followed by 0.1 mg/kg of subcutaneous NIMO; (3) O2 21% followed by vehicle (60% polyethylene glycol/40% methanol); (4) O2 10%; (5) O2 10% then NIMO; (6) O2 10% then vehicle. The Object Recognition Test (ORT) was given once either on Day 1 or Day 7 to assess changes in short-term memory. ORT exploits the tendency of mice to prefer novel over familiar objects. Two identical objects were placed in an arena for 15 minutes of training. During the testing 1 hour later, one of the objects was replaced by a new object. Recognition Index (RI) was used to compare performance. It is defined as the time spent exploring the novel object divided by the time spent exploring both objects, the novel plus the familiar, and this ratio is converted to a percentage. RI was analyzed with analysis of variance. Tukey Honestly Significant Difference tests were used for post hoc comparisons when appropriate. P values <0.05 were considered significant.
RESULTS: RI for the control group was 68.3% (SE+/-3.6%). RI was 53.7% (SE+/-3.8%) for the 10% O2 group on the first posttreatment day. O2 saturation (SpO2) for the hypoxic group was 71.7% (SE+/-0.5%). By Day 7, RI for the 10% O2 group increased to 64.2% (SE+/-4.7%), which was not significantly different from control. On Day 1, RI was 68.6% (SE+/-5.2%) for hypoxic rodents treated with NIMO. These results were statistically significant. Low RI indicates impaired working memory and high RI indicates intact working memory. These results suggest that NIMO prevented impairment of working memory after moderate hypoxia.
CONCLUSIONS: NIMO reverses the disturbance of short-term working memory caused by moderate hypoxia in mice. The results may have implications for cognitive changes linked to Ca homeostasis in the postoperative period.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19295393     DOI: 10.1097/ANA.0b013e3181920d28

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  6 in total

1.  Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease.

Authors:  Saravanaraman Ponne; Chinnadurai Raj Kumar; Rathanam Boopathy
Journal:  Metab Brain Dis       Date:  2019-11-05       Impact factor: 3.584

2.  Nimodipine prevents memory impairment caused by nitroglycerin-induced hypotension in adult mice.

Authors:  Alex Bekker; Michael Haile; Yong-Sheng Li; Samuel Galoyan; Edwardo Garcia; David Quartermain; Angela Kamer; Thomas Blanck
Journal:  Anesth Analg       Date:  2009-12       Impact factor: 5.108

3.  Effects of nimodipine on postoperative delirium in elderly under general anesthesia: A prospective, randomized, controlled clinical trial.

Authors:  Ya-Nan Li; Qi Zhang; Chun-Ping Yin; Yang-Yang Guo; Shu-Ping Huo; Liang Wang; Qiu-Jun Wang
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

4.  Pretreatment with nimodipine reduces incidence of POCD by decreasing calcineurin mediated hippocampal neuroapoptosis in aged rats.

Authors:  Qi Zhang; Yanan Li; Yongjuan Bao; Chunping Yin; Xi Xin; Yangyang Guo; Fang Gao; Shuping Huo; Xiuli Wang; Qiujun Wang
Journal:  BMC Anesthesiol       Date:  2018-04-16       Impact factor: 2.217

5.  A Novel 5-Chloro-N-phenyl-1H-indole-2-carboxamide Derivative as Brain-Type Glycogen Phosphorylase Inhibitor: Potential Therapeutic Effect on Cerebral Ischemia.

Authors:  Yatao Huang; Shuai Li; Youde Wang; Zhiwei Yan; Yachun Guo; Liying Zhang
Journal:  Molecules       Date:  2022-09-26       Impact factor: 4.927

6.  Calcium channel blockade with nimodipine reverses MRI evidence of cerebral oedema following acute hypoxia.

Authors:  Matthew J Rowland; Martyn Ezra; Anderson Winkler; Payashi Garry; Catherine Lamb; Michael Kelly; Thomas W Okell; Jon Westbrook; Richard G Wise; Gwenaëlle Douaud; Kyle Ts Pattinson
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-31       Impact factor: 6.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.